Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

08. Mai 2026 05:38 ET | Quelle: Research and Markets

Therapeutic Drug Monitoring Research Report 2026 - Global Market Analysis, Competitive Landscape, Opportunities, and Forecasts, 2021-2025 & 2025-2031

Dublin, May 08, 2026 (GLOBE NEWSWIRE) -- The "Therapeutic Drug Monitoring Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F" has been added to ...
06. Mai 2026 11:34 ET | Quelle: Research and Markets

2 Day FDA (Food and Drug Administration) Drug Approval Process Training Course: Procedures for Submission of INDs, NDAs, ANDAs and 505(b)(2) (ONLINE EVENT: Sept 24th - Sept 25th, 2026)

Dublin, May 06, 2026 (GLOBE NEWSWIRE) -- The "The FDA (Food and Drug Administration) Drug Approval Process Training Course (Sept 24th - Sept 25th, 2026)" training has been added to ...
29. April 2026 07:00 ET | Quelle: X4 Pharmaceuticals

X4 Pharmaceuticals Announces European Commission Approval of XOLREMDI® (Mavorixafor), the First and Only Authorized Treatment for Patients with WHIM Syndrome in the European Union

- European Commercialization will be Led by X4 Pharmaceuticals’ Partner, Norgine - - Global, Pivotal Phase 3 Clinical Trial Ongoing to Evaluate Mavorixafor in Chronic Neutropenia - BOSTON, April ...
30. März 2026 08:34 ET | Quelle: Muscular Dystrophy Association

FDA Approves High Dose Regimen of SPINRAZA® for Spinal Muscular Atrophy, Reflecting Progress Made Possible Through Decades of MDA Supported Research

New York, March 30, 2026 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) celebrates today’s announcement that the U.S. Food and Drug Administration (FDA) has approved a High Dose...
23. Dezember 2025 09:17 ET | Quelle: Research and Markets

Pharmaceutical Regulatory Affairs in Russia and the Eurasian Union Training Course (Online Event: Mar 5th - Mar 6th, 2026)

Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Regulatory Affairs in Russia and the Eurasian Union Training Course (Mar 5th - Mar 6th, 2026)" training has been added to ...
12. Dezember 2025 04:01 ET | Quelle: Research and Markets

2 Day Virtual FDA (Food and Drug Administration) Drug Approval Process Training Course (Feb 23rd - Feb 24th, 2026)

Dublin, Dec. 12, 2025 (GLOBE NEWSWIRE) -- The "The FDA (Food and Drug Administration) Drug Approval Process Training Course (Feb 23rd - Feb 24th, 2026)" training has been added to ...
05. Dezember 2025 04:03 ET | Quelle: Research and Markets

China's Licensing Trends Shaping Global Drug Development Analysis Report 2025: Parent Companies Benefitted from Upfront Payments for R&D, Gaining Equity in Novel Chinese Therapeutics

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "China's Licensing Trends Shaping Global Drug Development" report has been added to ResearchAndMarkets.com's offering.Over the past five years, China's...
14. November 2025 09:14 ET | Quelle: Research and Markets

China's Evolution in Global Drug Development and Clinical Trials Markets

Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The "China's Evolution in Global Drug Development and Clinical Trials" report has been added to ResearchAndMarkets.com's offering. This report examines...
10. September 2025 09:15 ET | Quelle: Research and Markets

Pharmaceutical Drug Development Annual Market Review 2024-2025 | Key Shifts and Strategic Priorities for Companies Navigating Evolving Pharma Ecosystem

Dublin, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Drug Development Annual Review - 2024" report has been added to ResearchAndMarkets.com's offering.This report investigates the year...
30. Juli 2025 07:40 ET | Quelle: Research and Markets

2 Day FDA (Food and Drug Administration) Drug Approval Process Training Course | Stay Ahead with Insights into IND, NDA, ANDA, and 505(b)(2) Submissions (ONLINE EVENT: October 7-8, 2025)

Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The "The FDA (Food and Drug Administration) Drug Approval Process Training Course" training has been added to ResearchAndMarkets.com's offering. The US...

Nächste Seite